During the past decade, Retina Associates Southwest, PC conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 11 clinical trials were completed, i.e. on average, 57.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 9 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Associates Southwest, PC" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Aura Biosciences" with 3 trials sponsored, "Allergan" with 2 trials sponsored, "Clearside Biomedical, Inc." with 1 trials sponsored and "Eyetech Pharmaceuticals" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Associates Southwest, PC" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "National Eye Institute (NEI)" with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Retina Associates Southwest, PC" are "Diabetic Macular Edema" (5 trials), "Choroidal Melanoma" (3 trials), "Geographic Atrophy" (3 trials), "Macular Edema" (3 trials) and "Macular Degeneration" (2 trials). Many other conditions were trialed in "Retina Associates Southwest, PC" in a lesser frequency.

Most popular intervention types in "Retina Associates Southwest, PC" are "Drug" (21 trials), "Other" (4 trials), "Procedure" (4 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (8 trials), "Sham Procedure" (8 trials), "Aflibercept" (4 trials), "Ranibizumab" (3 trials) and "Lampalizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Retina Associates Southwest, PC" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Retina Associates Southwest, PC". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Retina Associates Southwest, PC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Associates Southwest, PC, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".